Product
Reteplase
Aliases
Retavase
Name
Retavase
INN Name
reteplase
FDA Approved
Yes
3 clinical trials
1 organization
5 indications
1 document
Indication
Heart diseaseIndication
Heart AttackIndication
Myocardial InfarctionIndication
strokeClinical trial
Effect of Low-dose Intracoronary Reteplase During Primary Percutaneous Coronary Intervention on Myocardial Infarct Size in Patients With Acute Myocardial InfarctionStatus: Terminated, Estimated PCD: 2023-01-31
Clinical trial
PATCAR Pilot Trial: A Phase 4 Study, Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery RevascularizationStatus: Completed, Estimated PCD: 2009-12-01
Clinical trial
Endovascular Stroke Treatment And Reteplase ProtocolStatus: Withdrawn, Estimated PCD: 2024-07-01
Document
DailyMed Label: RetavaseOrganization
Chiesi USA, Inc.